Logo
Logo


ISSN: 0300-9041
ISSNe: 2594-2034


Indizada en: SciELO, Índice Médico Latinoamericano, LILACS, Medline
Editada por la Federación Mexicana de Colegios de Obstetricia, y Ginecologia AC
Fundada por la Asociación Mexicana de Ginecología y Obstetricia en 1945
 

INFORMACIÓN EXCLUSIVA PARA LOS PROFESIONALES DE LA SALUD


Periodicidad: continua
Abreviatura: Ginecol Obstet Mex
ISSN: 0300-9041
ISSNe: 2594-2034
Indizada en: Scimago, Índice Médico Latinoamericano, Lilacs, Medline, Science Citation Index, Ulrich, Ebsco.

Linfoma no Hodgkin estadio IV con metástasis mamaria y vaginal

Non Hodgkin lymphoama stage IV with breast and vaginal metastasis.

Ginecol Obstet Mex. 2018 enero;86(1):62-69.

https://doi.org/10.24245/gom.v86i1.1609

Cabistany-Esqué AC,1 Franco-Serrano C,2 Guardia-Dodorico L,2 Gabasa-Gorgas L,3 Aragón-Sanz MA,2 Martínez-Medel J2,3

1 Servicio de Urgencias, Hospital Universitario Miguel Servet, Zaragoza, España.
2 Servicio de Ginecología y Obstetricia, Hospital de Barbastro, Barbastro, España.
3 Servicio de Ginecología y Obstetricia, Hospital Clínico Universitario Lozano Blesa, Zaragoza, España.


Corrrespondencia:

Dr. Jorge Martínez Medel
jmartme@gmail.com

Debe citarse como:

Cabistany-Esqué AC, Franco-Serrano C, Guardia-Dodorico L, Gabasa-Gorgas L, Aragón-Sanz MA, Martínez-Medel J. Linfoma no Hodgkin estadio IV con metástasis mamaria y vaginal. Ginecol Obstet Mex. 2018 enero;86(1):62-69. DOI: https://doi.org/10.24245/gom.v86i1.1609

Resumen

ANTECEDENTES: la afectación mamaria por un linfoma es poco frecuente; casi siempre se trata de linfomas tipo B que se caracterizan por falta de especificidad clínica y radiológica, lo que dificulta el diagnóstico diferencial con tumoraciones mamarias de otro origen.

CASO CLÍNICO: paciente de 72 años de edad, con antecedentes de hipercolesterolemia, hipertensión arterial, artrosis y depresión, con dos partos y menopausia a los 55 años. Madre con antecedente de cáncer de mama posmenopáusico. En la mamografía de la mama derecha se encontró una masa retroareolar de 8 cm, de contornos mal definidos y una adenopatía axilar con engrosamiento cortical. La biopsia reportó un linfoma no Hodgkin B de alto grado. Se administraron 8 ciclos de quimioterapia con el esquema R-CHOP. Luego de este esquema el PET-TC mostró una lesión mamaria derecha residual, metabólicamente inactiva, sin enfermedad nodal ni extramamaria supra ni infradiafragmática.

CONCLUSIONES: una neoplasia maligna mamaria no siempre se trata de un carcinoma ductal o lobulillar. Es necesario valorar la posibilidad de otras estirpes histológicas o, incluso, de una afectación metastásica. La entrevista y exploración adecuadas son fundamentales para una buena orientación diagnóstica.

PALABRAS CLAVE: Mamario; tumores mamarios; cáncer de mama posmenopáusico; no Hodgkin; carcinoma lobulillar.

Abstract

BACKGROUND: the mammary affectation by a lymphoma is not frequent; it almost always involves type B lymphomas. It is characterized by a lack of clinical and radiological specificity, which makes differential diagnosis difficult with mammary tumors of another origin.

CLINICAL CASE: A 72-year-old patient with a history of hypercholesterolemia, hypertension, osteoarthritis and depression, with two deliveries and menopause at 55 years of age. Mother with a history of postmenopausal breast cancer. The mammography of the right breast reported the existence of a retroareolar mass of 8 cm, of ill-defined contours and an axillary adenopathy with cortical thickening. The biopsy reported a high-grade non-Hodgkin B lymphoma. 8 cycles of chemotherapy were administered with the R-CHOP scheme. After this procedure, the PET-CT showed a residual, metabolically inactive right mammary lesion, with nodal or extramammary supra or infradiaphragmatic disease.

CONCLUSIONS: A malignant mammary neoplasm is not always a ductal or lobular carcinoma. It is necessary to evaluate the possibility of other histological strains or, even, of a metastatic affectation. The adequate interview and exploration are fundamental for a good diagnostic orientation.

KEYWORDS: Mammary; mammary tumors; postmenopausal breast cancer; non Hodgkin; lobular carcinoma.

    1. Letzkus J, Peralta O, Ivanova G, Gamboa J, Belmar A, Del Castillo C, et al. Linfoma primario de la mama. Rev Chil Obstet Ginecol. 2002;67(2):148-152.
    2. Meyer JE, Kopans DB, Long JC. Mammographic appearance of malignant lymphoma of the breast. Radiology. 1980;135:623-6.
    3. Liberman L, Giess CS, Dershaw DD, Louie DC, Deutch BM. Non- Hodgkin lymphoma of the breast: imaging characteristics and correlation with histopathologic findings. Radiology. 1994;192:157-60.
    4. Cheah C, Campbell B, Seymour J. Tumor Review Primary breast lymphoma. Cancer Treat Rev. 2014;40:900-8.
    5. Jeanneret-Sozzi W, Taghian A, Epelbaum R, Poortmans P, Zwahlen D, Amsler B, et al. Primary breast lymphoma: patient profile, outcome and prognostic factors. A multicentre Rare Cancer Network study. BMC Cancer. 2008;8:1471-2407.
    6. Santillan I, Regojo R, Espada M, Hardisson D, De Santiago J. Linfoma secundario de mama. Prog Obstet Ginecol. 2007;50:615-9.
    7. Alberca A, Bertelli JL, Núñez P, García EP, Ruescas FJ, Pardo R, Alberca M. Linfoma no Hodgkin primario en la mama: reporte de un caso. Ginecol Obstet Mex. 2016;84(4):257-264.
    8. Caon J, Wai ES, Hart J, Alexander C, Truong PT, Sehn LH, et al. Treatment and outcomes of primary breast lymphoma. Clin Breast Cancer. 2012;12:412-9.
    9. Murillo C, Escobar P, Fuentes E, Alvarado J. Linfoma y su expresión en patología mamaria. Rev Obstet Ginecol-Hosp Santiago Oriente Dr Luis Tisne Brousse. 2007;2(1):49-52.
    10. Ryan G, Martinelli G, Kuper-Hommel M, Tsang R, Pruneri G, Yuen K, et al. Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group. Ann Oncol. 2008;19:233-41.
    11. Surov A, Holzhausen HJ, Wienke A, Schmidt J, Thomssen C, Arnold D, et al. Primary and secondary breast lymphoma: prevalence, clinical signs and radiological features. Br J Radiol. 2012;85:e195-205.
    12. Sabaté JM, Gómez A, Torrubia S, Camins A, Roson N, De Las Heras P, et al. Lymphoma of the breast: clinical and radiologic features with pathologic correlation in 28 patients. Breast J. 2002;8:294-304.
    13. Validire P, Capovilla M, Asselain B, et al. Primary breast non-Hodgkin’s lymphoma: a large single center study of initial characteristics, natural history, and prognostic factors. Am J Hematol. 2009;84:133-9.
    14. Martinelli G, Ryan G, Seymour JF, et al. Primary follicular and marginal-zone lymphoma of the breast: clinical features, prognostic factors and outcome: a study by the International Extranodal Lymphoma Study Group. Ann Oncol. 2009;20:1993-9.
    15. Ferbeyre-Binelfaa L, Cavazos-Samánb C, Salinas-García JC. Linfoma no Hodgkin primario de mama: reporte de un caso y revisión de la literatura. GAMO. 2013;12(6):453-458.
    16. Bobrow LG, Richards MA, Happerfield LC, et al. Breast lymphomas: a clinicopathologic review. Hum Pathol. 1993;24:274-8.
    17. Ferguson DJP. Intraepithelial lymphocytes and macrophages in the normal breast. Virchows Arch. 1985;407:369-78.
    18. García-Bolado A, Gorriño O, López-Valverde M, Grande D. Linfoma de mama. Radiología. 2005;47(1):29-31.
    19. Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, et al. Harrison principios de Medicina Interna. Volumen 1. 16 edición. Madrid: Interamericana, 2005;523-531.
    20. Lymphoid neoplasms. In: American Joint Committee on Cancer: AJCC Cancer Staging Manual. 6th ed. New York: Springer, 2002; 393-406.
    21. Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, et al. Recommendations for initial evaluation, staging and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol. 2014;32(27):3059-68.
    22. Silva V, Correia P, Oliveira N, Sa L. Primary vaginal non-Hodgkin´s lymphoma: report of a rare clinical entity. Clin Pract 2015;5:821.
    23. Kosari F, Daneshbod Y, Parwaresch R, Krams M, Wacker HH. Lymphomas of the female genital tract: a study of 186 cases and review of the literature. Am J Surg Pathol. 2005;29(11):1512-20.
    24. Mouna B, Saber B, Tijani EH, Hind M, Amina T, Hassan E. Primary malignant non-Hodgkin’s lymphoma of the breast: a study of seven cases and literature review. World J Surg Oncol. 2012;10:151.
    25. Caon J, Wai E, Hart J, Alexander C, Truong P, Sehn L, Connors J. Treatment and outcomes of primary breast lymphoma. Clin Breast Cancer 2012;12(6):412-9. http://dx.doi.org/10.1016/j.clbc.2012.07.006
    26. El Ghazawy IM, Singletary SE. Primary breast lymphoma: the role of mastectomy and the importance of lymph node status. Ann Surg. 1991;214(6):724-6.
    27. Jennings WC, Baker RS, Murray SS, Howard CA, Parker DE, Peabody LF, Vice HM, Sheehan WW, Broughan TA. Surgical management of primary lymphoma of the breast. Ann Surg. 2007;245(5):784-9.
    28. Ryan G, Martinelli G, Kuper-Hommel M, Tsang R, Pruneri G, Yuen K, et al. Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group. Ann Oncol. 2008;19:233-41.
    29. Solal-Celigny P, Roy P, Colombat P, White J, Armitage JO, Arranz-Saez R, et al. Follicular lymphoma international prognostic index. Blood. 2004;104(5):1258-65.
    30. Federico M, Bellei M, Marcheselli L, Luminari S, Lopez-Guillermo A, Vitolo U, et al. Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project. J Clin Oncol. 2009;27(27):4555-62.

Comentarios